
DeepDerm provides clinicians a non-invasive way to detect skin cancer earlier by analyzing skin lesions in real time. It uses multimodal imaging—combining thermal, spectral, and polarization data—with proprietary AI (DermAI) to extract physiological and morphological signals invisible to the human eye. The product is delivered as a clinical AI imaging and SaaS platform for dermatologists, skin cancer screening clinics, and teledermatology workflows. DeepDerm partners with clinical institutions like MoleMap and PeterMac and targets regulatory clearance and deployment in global screening markets.

DeepDerm provides clinicians a non-invasive way to detect skin cancer earlier by analyzing skin lesions in real time. It uses multimodal imaging—combining thermal, spectral, and polarization data—with proprietary AI (DermAI) to extract physiological and morphological signals invisible to the human eye. The product is delivered as a clinical AI imaging and SaaS platform for dermatologists, skin cancer screening clinics, and teledermatology workflows. DeepDerm partners with clinical institutions like MoleMap and PeterMac and targets regulatory clearance and deployment in global screening markets.